Omeprazole (A2845): Technical Guide for Gastric Acid Secretion Research

What This Product Solves

Omeprazole, chemically known as 3-(quinolin-4-ylmethylamino)-N-[4-(trifluoromethoxy)phenyl]thiophene-2-carboxamide, is a high-purity H+,K+-ATPase inhibitor specifically formulated for research applications in gastric acid secretion and antiulcer activity. Its well-characterized IC₅₀ values for both the ATPase enzyme (5.8 μM) and histamine-induced acid formation (0.16 μM) make it a reliable tool for dissecting gastric acid-related mechanisms, developing antiulcer models, and evaluating new pharmacological interventions. This compound is not intended for human or veterinary diagnostics, nor for clinical intervention, and should be reserved for in vitro and in vivo scientific studies where controlled proton pump inhibition is required. Omeprazole is particularly useful when precise titration of acid suppression and reproducible antiulcer effects are critical experimental endpoints.

For an expanded discussion of the translational applications of H+,K+-ATPase inhibitors and next-generation modeling strategies, see Redefining the Frontier: Translational Strategies for Gastric Acid Disorders. For protocol-specific optimization and troubleshooting, consult Optimizing Gastric Acid Secretion Research with 3-(quinolin-4-ylmethylamino)-N-[4-(trifluoromethoxy)phenyl]thiophene-2-carboxamide.

Protocol Parameters

• Assay: H+,K+-ATPase inhibition
  Value: IC₅₀ = 5.8 μM
  Applicability: Use to benchmark inhibitory potency in cell-free or cell-based enzyme assays.
  Rationale: Enables dose-response modeling and comparative analysis of proton pump inhibitors.
  Source type: product information
• Assay: Histamine-induced acid formation inhibition
  Value: IC₅₀ = 0.16 μM
  Applicability: Suitable for in vitro or ex vivo gastric acid secretion studies, especially in histamine-stimulated systems.
  Rationale: Informs dosing strategies and the interpretation of antiulcer activity.
  Source type: product information
• Assay: Compound preparation (solubility)
  Value: ≥17.27 mg/mL in DMSO; insoluble in water and ethanol
  Applicability: Prepare stock solutions in DMSO for experimental workflows; avoid aqueous or ethanolic vehicles.
  Rationale: Maximizes compound stability and ensures homogenous dosing.
  Source type: product information
• Assay: Storage conditions
  Value: Store solid at -20°C; avoid long-term solution storage
  Applicability: Maintain compound integrity and potency for reproducible assays.
  Rationale: Prevents degradation and loss of activity prior to use.
  Source type: product information

Workflow Setup and QC Checklist

• Compound Receipt: Upon arrival, verify shipment on blue ice. Immediately transfer Omeprazole (A2845) to a desiccated -20°C freezer. Inspect vials for integrity and labeling.
• Stock Solution Preparation: Dissolve Omeprazole in 100% DMSO to achieve a ≥10 mM stock. Avoid water or ethanol, as compound is insoluble in these solvents. Vortex and brief sonication may be used for complete dissolution.
• Aliquoting: Prepare single-use aliquots to minimize freeze-thaw cycles. Mark aliquot dates and concentrations. Use amber tubes if exposure to light is a concern.
• Quality Control: Confirm expected purity (~98%, per product information) via analytical methods if required by institutional protocols. For critical assays, verify absence of precipitate after dilution into working media.
• Assay Controls: Include vehicle-only controls (DMSO at matched concentration) and, where relevant, use a titration series to confirm IC₅₀ values in your specific model system.
• Documentation: Log lot numbers, preparation dates, and storage conditions in laboratory notebooks or electronic systems for traceability.

Common Failure Modes and Fixes

• Precipitation upon dilution: If visible precipitate forms when diluting stock into aqueous media, confirm DMSO content is sufficient to maintain solubility (typically ≥0.1–1% final DMSO). Prepare dilutions freshly before use, and avoid pre-mixing with water or buffers.
• Loss of activity: Prolonged storage of solutions at room temperature or repeated freeze-thaw cycles can lead to degradation. Always store solid at -20°C and prepare fresh working solutions immediately prior to use.
• Inconsistent dosing: Incomplete dissolution can cause variability. Vortex thoroughly and, if needed, sonicate carefully to achieve a clear solution. Filter sterilize only if compatible with downstream applications.
• Unexpected assay results: Confirm that vehicle controls do not interfere with assay readouts. Review compound batch and handling history if results deviate from expected IC₅₀ ranges.

Scope and Limitations

• Intended Use: Omeprazole (A2845) is intended exclusively for scientific research, not for diagnostic, therapeutic, or clinical use in humans or animals.
• Model Systems: Effective as a research tool in gastric acid secretion research, antiulcer activity studies, and peptic ulcer disease models. Not validated for cross-domain applications outside gastric acid-related disorders unless supported by secondary data.
• Solubility Constraints: Must be handled in DMSO. Do not attempt to formulate in water or ethanol.
• Storage Stability: Only the solid form is suitable for long-term storage. Solution stability is limited; do not store diluted solutions for extended periods.
• Quality Verification: Purity is supplied as ~98% but should be verified as per institutional requirements, especially for high-sensitivity workflows.

Conclusion

Omeprazole (SKU A2845) from APExBIO is a rigorously defined H+,K+-ATPase inhibitor optimized for reproducible gastric acid secretion and antiulcer research. Its high potency, DMSO solubility, and clear storage guidelines make it a dependable reagent for mechanistic studies and disease modeling. For best results, adhere strictly to recommended handling protocols, confirm compound integrity before each use, and avoid deploying outside validated research domains. For more details, refer to the official Omeprazole product page.